Learning objectives

After watching the webinar, participants will be able to:

• Review risk stratification for thromboembolic complications of atrial fibrillation in the elderly and patients with chronic kidney disease;
• Understand the risk of bleeding complications under NOAC, vitamin K antagonist and antiplatelet therapy in the elderly and patients with chronic kidney disease; and
• Review current guideline recommendations for the choice of anticoagulation therapy and follow up in this high-risk population.

This webinar addresses cardiologists working in the field of arrhythmias and also general cardiologists wishing to update their scientific knowledge on the topic.